US 8394846
Dual-acting antihypertensive agents
granted A61PA61P43/00A61P9/04
Quick answer
US patent 8394846 (Dual-acting antihypertensive agents) held by Theravance, Inc. expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61P, A61P43/00, A61P9/04, A61P9/12